Semler Scientific, Inc.

Semler Scientific, Inc. Stock Forecast & Price Prediction

Live Semler Scientific, Inc. Stock (SMLR) Price
$25.53

1

Ratings

  • Buy 1
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$25.53

P/E Ratio

12.77

Volume Traded Today

$96,416

Dividend

Dividends not available for SMLR

52 Week High/low

53.38/20.88

Semler Scientific, Inc. Market Cap

$181.2M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $SMLR ๐Ÿ›‘

Before you buy SMLR you'll want to see this list of ten stocks that have huge potential. Want to see if SMLR made the cut? Enter your email below

SMLR Summary

The Semler Scientific, Inc. (SMLR) share price is expected to increase by 56.68% over the next year. This is based on calculating the average 12-month share price estimate provided by 1 stock analysts who have covered SMLR. Price targets range from $40 at the low end to $40 at the high end. The current analyst consensus for SMLR is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

SMLR Analyst Ratings

About 1 Wall Street analysts have assignedSMLR 1 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Semler Scientific, Inc. to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on SMLR. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

SMLR stock forecast by analyst

These are the latest 20 analyst ratings of SMLR.

Analyst/Firm

Rating

Price Target

Change

Date

Marc Wiesenberger
B. Riley Securities

Neutral

$45

Downgrade

Nov 2, 2022
Marc Wiesenberger
B. Riley Securities

Buy

$60

Maintains

May 3, 2022
Marc Wiesenberger
B. Riley Securities

Buy

$70

Maintains

Mar 7, 2022
Marc Wiesenberger
B. Riley Securities

Buy

$145

Maintains

Nov 2, 2021
Marc Wiesenberger
B. Riley Securities

Buy

$175

Maintains

Oct 26, 2021

B. Riley FBR

Buy


Maintains

May 4, 2021
Marc Wiesenberger
B. Riley Securities

Buy

$151

Maintains

May 4, 2021

B. Riley FBR

Buy


Initiates

Jun 23, 2020

B. Riley Securities

Buy


Initiates

Jun 23, 2020

HC Wainwright & Co.



Initiates

Jul 29, 2015

H.C. Wainwright



Initiates

Jul 29, 2015

Aegis Capital

Buy


Initiates

Jun 5, 2014

SMLR Company Information

  • Company Name: Semler Scientific, Inc.
  • Industry: Healthcare technology solutions
  • Location: Santa Clara, California
  • Incorporation Year: 2007
  • Core Products:
    • QuantaFlo: A four-minute in-office blood flow test for assessing vascular conditions.
    • Insulin Insights: Software for optimizing outpatient insulin dosing.
  • Target Customers:
    • Cardiologists
    • Internists
    • Nephrologists
    • Endocrinologists
    • Podiatrists
    • Family practitioners
    • Healthcare insurance plans
    • Integrated delivery networks
    • Independent physician groups
    • Companies in healthcare contracting (e.g., risk assessment groups, retailers)
  • Sales Channels: Products are offered through sales representatives and distributors.
SMLR
Semler Scientific, Inc. (SMLR)

When did it IPO

N/A

Staff Count

92

Country

United States

Sector/Industry

Healthcare/Medical Devices

CEO

Dr. Douglas Murphy-Chutorian M.D.

Market Cap

$181.2M

Semler Scientific, Inc. (SMLR) Financial Data

In 2023, SMLR generated $68.2M in revenue, which was a increase of 20.28% from the previous year. This can be seen as a signal that SMLR's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$38.6M

Revenue From 2021

$53.0M

37.36 %
From Previous Year

Revenue From 2022

$56.7M

6.90 %
From Previous Year

Revenue From 2023

$68.2M

20.28 %
From Previous Year
  • Revenue TTM $61.7M
  • Operating Margin TTM 37.0%
  • Gross profit TTM $61.2M
  • Return on assets TTM 17.1%
  • Return on equity TTM 22.0%
  • Profit Margin 25.6%
  • Book Value Per Share 11.22%
  • Market capitalisation $181.2M
  • Revenue for 2021 $53.0M
  • Revenue for 2022 $56.7M
  • Revenue for 2023 $68.2M
  • EPS this year (TTM) $2.03

Semler Scientific, Inc. (SMLR) Latest News

No news data available.

...

SMLR Frequently asked questions

The highest forecasted price for SMLR is $40 from at .

The lowest forecasted price for SMLR is $40 from from

The SMLR analyst ratings consensus are 1 buy ratings, 0 hold ratings, and 0 sell ratings.